Related references
Note: Only part of the references are listed.Neuropeptide-Y causes coronary microvascular constriction and is associated with reduced ejection fraction following ST-elevation myocardial infarction
Neil Herring et al.
EUROPEAN HEART JOURNAL (2019)
Cardiac arrhythmias in the emergency settings of acute coronary syndrome and revascularization: an European Heart Rhythm Association (EHRA) consensus document, endorsed by the European Association of Percutaneous Cardiovascular Interventions (EAPCI), and European Acute Cardiovascular Care Association (ACCA)
Zbigniew Kalarus et al.
EUROPACE (2019)
The autonomic nervous system and cardiac arrhythmias: current concepts and emerging therapies (vol 16, pg 707, 2019)
Neil Herring et al.
NATURE REVIEWS CARDIOLOGY (2019)
2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC)
Borja Ibanez et al.
EUROPEAN HEART JOURNAL (2018)
The Role of Neuropeptide Y in Cardiovascular Health and Disease
Cheryl M. J. Tan et al.
FRONTIERS IN PHYSIOLOGY (2018)
Remodeling of stellate ganglion neurons after spatially targeted myocardial infarction: Neuropeptide and morphologic changes
Olujimi A. Ajijola et al.
HEART RHYTHM (2015)
Ca2+/calmodulin dependent kinase II: A critical mediator in determining reperfusion outcomes in the heart?
James R. Bell et al.
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY (2014)
Cardiac arrhythmias in acute coronary syndromes: position paper from the joint EHRA, ACCA, and EAPCI task force
Bulent Gorenek et al.
EUROPACE (2014)
Cardiac sympathetic denervation to prevent life-threatening arrhythmias
Peter J. Schwartz
NATURE REVIEWS CARDIOLOGY (2014)
Cardiac sympathetic dysfunction in the prehypertensive spontaneously hypertensive rat
Julia Shanks et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2013)
Relationship of plasma neuropeptide Y with angiographic, electrocardiographic and coronary physiology indices of reperfusion during ST elevation myocardial infarction
Florim Cuculi et al.
HEART (2013)
The cardiac sympathetic co-transmitter galanin reduces acetylcholine release and vagal bradycardia: Implications for neural control of cardiac excitability
Neil Herring et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2012)
Neuropeptide Y reduces acetylcholine release and vagal bradycardia via a Y2 receptor-mediated, protein kinase C-dependent pathway
Neil Herring et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2008)
Galanin modulates cholinergic neurotransmission in the heart
EK Potter et al.
NEUROPEPTIDES (2005)
Neuropeptide Y rapidly enhances [Ca2+](i) transients and Ca2+ sparks in adult rat ventricular myocytes through Y-1 receptor and PLC activation
MD Heredia et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2005)
Neuropeptide Y increases 4-aminopyridine-sensitive transient outward potassium current in rat ventricular myocytes
MP Heredia et al.
BRITISH JOURNAL OF PHARMACOLOGY (2002)
Arrhythmogenesis and contractile dysfunction in heart failure -: Roles of sodium-calcium exchange, inward rectifier potassium current, and residual β-adrenergic responsiveness
SM Pogwizd et al.
CIRCULATION RESEARCH (2001)
Share Paper
